Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade
Evan R. Abt(Sylvester Comprehensive Cancer Center), Owen N. Witte(Parker Institute for Cancer Immunotherapy)
Cited by 0
Related Papers
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire
|Proceedings of the National Academy of Sciences|2024|5